Federal Register / Vol. 77, No. 150 / Friday, August 3, 2012 / Notices 46439 

1http://www.cms.gov/Research-Statistics-Dataand-Systems/Monitoring-Programs/CERT/ 

Downloads/CERT_Nov_2010_Appendix_-final.pdf 

Supplemental Appendix, Table B2. 

individual patients in Table 1 of the IJC 

paper and their inappropriate impact on 

the antibody values reported in Table II 

of the IJC paper were reported in detail 

by Respondent to the Managing Editor 

in IJC in email communications dated 

September 24 and 29, 2008. 

Dr. Ravindranath has entered into a 

Voluntary Settlement Agreement and 

has voluntarily agreed for a period of 

three (3) years, beginning on July 2, 

2012: 

(1) To have any PHS-supported 

research supervised; Respondent agreed 

that prior to the submission of an 

application for PHS support for a 

research project on which the 

Respondent’s participation is proposed 

and prior to Respondent’s participation 

in any capacity on PHS-supported 

research, Respondent shall ensure that a 

plan for supervision of Respondent’s 

duties is submitted to ORI for approval; 

the supervision plan must be designed 

to ensure the scientific integrity of 

Respondent’s research contribution; 

Respondent agreed that he shall not 

participate in any PHS-supported 

research until such a supervision plan is 

submitted to and approved by ORI; 

Respondent agreed to maintain 

responsibility for compliance with the 

agreed upon supervision plan; 

(2) That any institution employing 

him shall submit, in conjunction with 

each application for PHS funds, or 

report, manuscript, or abstract involving 

PHS- supported research in which 

Respondent is involved, a certification 

to ORI that the data provided by 

Respondent are based on actual 

experiments or are otherwise 

legitimately derived, that the data, 

procedures, and methodology are 

accurately reported in the application, 

report, manuscript, or abstract, and that 

the text in such submissions is his own 

or properly cites the source of copied 

language and ideas; and 

(3) To exclude himself voluntarily 

from serving in any advisory capacity to 

PHS including, but not limited to, 

service on any PHS advisory committee, 

board, and/or peer review committee, or 

as a consultant. 

FOR FURTHER INFORMATION CONTACT: 

Director, Division of Investigative 

Oversight, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852, (240) 453–8800. 

John Dahlberg, 

Director, Division of Investigative Oversight, 

Office of Research Integrity. 

[FR Doc. 2012–18990 Filed 8–2–12; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Decision To Evaluate a Petition To 

Designate a Class of Employees From 

the Baker Brothers Site in Toledo, 

Ohio, To Be Included in the Special 

Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: NIOSH gives notice as 

required by 42 CFR 83.12(e) of a 

decision to evaluate a petition to 

designate a class of employees from the 

Bakers Brothers site in Toledo, Ohio, to 

be included in the Special Exposure 

Cohort under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. The initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Baker Brothers. 

Location: Toledo, Ohio. 

Job Titles and/or Job Duties: All 

employees who worked in any area. 

Period of Employment: June 1, 1943 to 

December 31, 1996. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–19047 Filed 8–2–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[CMS–6042–N] 

Medicare Program; Prior Authorization 

for Power Mobility Device (PMD) 

Demonstration 

AGENCY: Centers for Medicare & 

Medicaid Services (CMS), HHS. 

ACTION: Notice. 

SUMMARY: This notice announces a 3- 

year Medicare Prior Authorization for 

Power Mobility Device (PMD) 

Demonstration for certain PMD codes in 

seven states where there have been high 

incidences of fraudulent claims and 

improper payments 

DATES: This demonstration begins on 

September 1, 2012. 

FOR FURTHER INFORMATION CONTACT: 

Daniel Schwartz, 410–786–4197. 

Questions regarding the Medicare 

Prior Authorization for PMD 

Demonstration should be sent to 

pademo@cms.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Power Mobility Devices have had 

historically high incidents of fraud and 

improper payments. PMD suppliers also 

continue to be subject to significant law 

enforcement investigation. 

The Health Care Fraud Prevention 

and Enforcement Action Team (HEAT) 

Task Force was launched in May 2009 

and is co-chaired by the Deputy 

Secretary of HHS and the Deputy 

Attorney General of DOJ. Medicare 

Fraud Strike Force teams are a key 

component of HEAT, since their 

inception and based on data driven 

investigations, prosecutors have filed 

more than 600 cases charging more than 

1,150 defendants who collectively billed 

the Medicare program more than $2.9 

billion in fraudulent claims. DME is a 

primary focus of investigation for these 

strike forces. 

The Comprehensive Error Rate 

Testing (CERT) Program noted in a 2010 

Report 1 that 92.6 percent of claims for 

motorized wheelchairs did not meet 

Medicare coverage requirements. 

Although we recognize that many 

improper payments are not the result of 

willful fraud, this error rate represents 

over $822 million dollars in estimated 

improper payments. 

II. Legislative Authority 

Section 402(a)(1)(J) of the Social 

Security Amendments of 1967, 42 

U.S.C. 1395b–1(a)(1)(J), authorizes the 

Secretary to conduct demonstrations 

designed to develop or demonstrate 

improved methods for the investigation 

and prosecution of fraud in the 

provision of care or services provided 

under the Medicare program. We plan to 

conduct a demonstration that 

implements a prior authorization 

process for power mobility devices 

(PMDs), an area with historically high 

levels of fraud and improper payments, 

to develop improved methods for the 

investigation and prosecution of fraud 


TKELLEY on DSK3SPTVN1PROD with NOTICES